Literature DB >> 14617499

Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men.

C J Reback1, S Larkins, S Shoptaw.   

Abstract

Medication adherence among persons with HIV infection is important not only because of the effect of non-adherence on an individual's health but also because non-adherence can lead to medication-resistant viral strains. However, adherence to HIV medications is difficult due to complex dosing regimens and side effects. This paper is a qualitative analysis of HIV medication adherence among gay and bisexual methamphetamine-abusing men enrolled in an outpatient drug treatment research project. As part of an open-ended, semi-structured interview, 23 HIV-infected men discussed the effects of their methamphetamine use on their medication adherence. Substance-use barriers to adherence were coded into two main themes: (1) planned non-adherence and (2) unplanned non-adherence. Planned non-adherence was a strategy for coping with demanding HIV medication schedules, or was linked to sexual behaviours while using methamphetamine or to fears of interaction effects from mixing methamphetamine with HIV medications. Participants did not define their medication regimen adjustments as non-adherence but as a way to achieve a sense of control over their lives. Unplanned non-adherence was linked to methamphetamine-related disruptions in food and sleep schedules. Findings are helpful in designing culturally specific HIV medication adherence interventions for this population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617499     DOI: 10.1080/09540120310001618621

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  62 in total

Review 1.  A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine.

Authors:  Radha Rajasingham; Matthew J Mimiaga; Jaclyn M White; Megan M Pinkston; Rachel P Baden; Jennifer A Mitty
Journal:  AIDS Patient Care STDS       Date:  2011-11-09       Impact factor: 5.078

2.  Predictors of Attrition in a Cohort Study of HIV Infection and Methamphetamine Dependence.

Authors:  J Cattie; M J Marquine; K A Bolden; L C Obermeit; E E Morgan; D R Franklin; A Umlauf; J M Beck; J H Atkinson; I Grant; S P Woods
Journal:  J Subst Use       Date:  2015-02-03

3.  Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.

Authors:  Keith A Hermanstyne; Glenn-Milo Santos; Eric Vittinghoff; Deirdre Santos; Grant Colfax; Phillip Coffin
Journal:  Drug Alcohol Depend       Date:  2014-08-05       Impact factor: 4.492

4.  Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy.

Authors:  Steven Shoptaw; Cathy J Reback
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

Review 5.  How qualitative methods contribute to understanding combination antiretroviral therapy adherence.

Authors:  Andrea Sankar; Carol Golin; Jane M Simoni; Mark Luborsky; Cynthia Pearson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

6.  Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Authors:  David J Moore; Kaitlin Blackstone; Steven Paul Woods; Ronald J Ellis; J Hampton Atkinson; Robert K Heaton; Igor Grant
Journal:  AIDS Care       Date:  2012-04-24

7.  Factors associated with HIV viral load in a respondent driven sample in Los Angeles.

Authors:  William D King; Sherry Larkins; Christopher Hucks-Ortiz; Pin-Chieh Wang; Pamina M Gorbach; Rose Veniegas; Steven Shoptaw
Journal:  AIDS Behav       Date:  2007-12-07

8.  Adaptation and implementation of HoMBReS: a community-level, evidence-based HIV behavioral intervention for heterosexual Latino men in the midwestern United States.

Authors:  Omar Martinez; Alexis M Roth; Guadalupe Kelle; Mario Downs; Scott D Rhodes
Journal:  AIDS Educ Prev       Date:  2014-02

Review 9.  The methamphetamine epidemic: implications for HIV prevention and treatment.

Authors:  Grant Colfax; Steven Shoptaw
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

10.  Methamphetamine inhibits HIV-1 replication in CD4+ T cells by modulating anti-HIV-1 miRNA expression.

Authors:  Chinmay K Mantri; Jyoti V Mantri; Jui Pandhare; Chandravanu Dash
Journal:  Am J Pathol       Date:  2013-10-26       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.